MiRNA-424 Protects Against Permanent Focal Cerebral Ischemia Injury in Mice Involving Suppressing Microglia Activation
- 1 June 2013
- journal article
- research article
- Published by Wolters Kluwer Health in Stroke
- Vol. 44 (6) , 1706-1713
Abstract
Background and Purpose—: We observed that microRNA-424 (miR-424) significantly decreased in an miRNA profile of circulating lymphocytes of patients with ischemic stroke. The present study focused on the potential and mechanism of miR-424 in protecting ischemic brain injury in mice. Methods—: Cerebral ischemia was induced by middle cerebral artery occlusion in C57/BL6 mice. Cerebral infarction volume, neuronal apoptosis, and microglia activation were determined by 2,3,5-triphenyltetrazolium chloride staining, immunofluorescence, and Western blot. BV2 microglial cell activity, cell cycle, mRNA, and protein levels of miR-424 targets were accessed by enzyme-linked immunosorbent assay, flow cytometry, real-time polymerase chain reaction, and Western blot, respectively. Results—: MiR-424 levels were decreased in the plasma of patients with acute ischemic stroke, as well as in mouse plasma and ipsilateral brain tissue at 4, 8, and 24 hours after ischemia, likewise, in the cortex, hippocampus, and basal ganglia, respectively, after 8-hour ischemia. Interestingly, pre- and post-treatment with overexpression of miR-424 both decreased cerebral infarction size and brain edema after middle cerebral artery occlusion. Meanwhile, lentiviral overexpression of miR-424 inhibited neuronal apoptosis and microglia activation, including suppressing ionized calcium binding adaptor molecule-1 immunoreactivity and protein level, and reduced tumor necrosis factor-α production. In vitro study demonstrated that miR-424 mimics caused G1 phase cell-cycle arrest, inhibited BV2 microglia activity, and reduced the mRNA and protein levels of CDC25A, cyclin D1, and CDK6 in BV2 microglial cells, which were upregulated in brain of middle cerebral artery occlusion mice. Conclusions—: MiR-424 overexpression lessened the ischemic brain injury through suppressing microglia activation by translational depression of key activators of G1/S transition, suggesting a novel miR-based intervention strategy for stroke.Keywords
This publication has 21 references indexed in Scilit:
- Pharmacological Revascularization of Acute Ischaemic StrokeCNS Drugs, 2012
- MicroRNA Destabilization Enables Dynamic Regulation of the miR-16 Family in Response to Cell-Cycle ChangesMolecular Cell, 2011
- Inhibition of interleukin-6 trans-signaling in the brain facilitates recovery from lipopolysaccharide-induced sickness behaviorJournal of Neuroinflammation, 2011
- MiR-322/424 and -503 Are Induced during Muscle Differentiation and Promote Cell Cycle Quiescence and Differentiation by Down-Regulation of Cdc25AMolecular Biology of the Cell, 2010
- Expression Profile of MicroRNAs in Young Stroke PatientsPLOS ONE, 2009
- The Therapeutic Potential of microRNAs in Nervous System Damage, Degeneration, and RepairNeuroMolecular Medicine, 2009
- Brain and Blood microRNA Expression Profiling of Ischemic Stroke, Intracerebral Hemorrhage, and Kainate SeizuresJournal of Cerebral Blood Flow & Metabolism, 2009
- miR-16 family induces cell cycle arrest by regulating multiple cell cycle genesNucleic Acids Research, 2008
- MicroRNA Expression in the Blood and Brain of Rats Subjected to Transient Focal Ischemia by Middle Cerebral Artery OcclusionStroke, 2008
- The interplay between the master transcription factor PU.1 and miR-424 regulates human monocyte/macrophage differentiationProceedings of the National Academy of Sciences, 2007